NAA10 and rheumatoid arthritis: While anti-MAA antibody levels have been shown to correlate with radiographic disease progression (39), cardiovascular and pulmonary complications (23, 36), and responses to biologic therapies (34), no study to date has investigated their correlation with heart failure in RA.